7th Eurasian Hematology Oncology Summit
2020 Update on MRD in AML: Does Decitabine Prolong RFS/OS in Newly Diagnosed Disease? Can Aza Help Achieve MRD Negativity? Is CC-486 Effective as Post-Remission Maintenance Therapy in Older Patients?
By
7th Eurasian Hematology Oncology Summit
FEATURING
Farhad Ravandi
By
7th Eurasian Hematology Oncology Summit
FEATURING
Farhad Ravandi
Login to view comments.
Click here to Login
